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A Systematic Evolution of Ligands by EXponential enrichment (SE-
LEX) experiment begins in round one with a random pool of oligonucleotides
in equilibrium solution with a target. Over a few rounds, oligonucleotides
having a high affinity for the target are selected. Data from a high throughput
SELEX experiment consists of lists of thousands of oligonucleotides sam-
pled after each round. Thus far, SELEX experiments have been very good at
suggesting the highest affinity oligonucleotide, but modeling lower affinity
recognition site variants has been difficult. Furthermore, an alignment step
has always been used prior to analyzing SELEX data.
We present a novel model, based on a biochemical parametrization of SE-
LEX, which allows us to use data from all rounds to estimate the affinities
of the oligonucleotides. Most notably, our model also aligns the oligonu-
cleotides. We use our model to analyze a SELEX experiment containing dou-
ble stranded DNA oligonucleotides and the transcription factor Bicoid as the
target. Our SELEX model outperformed other published methods for predict-
ing putative binding sites for Bicoid as indicated by the results of an in-vivo
ChIP-chip experiment.
1. Introduction. Transcription factors are proteins that regulate gene tran-
scription of DNA by binding to DNA sequence motifs within the genome. Map-
ping these DNA recognition sequences and determining the relationship between
DNA sequence and transcription factor binding affinity is central to understanding
the regulation of gene expression. Transcription factors comprise approximately
Received April 2010; revised November 2011.
1Joint first authorship.
2Supported in part by NIH-R01GM075312.
3Supported in part by NSERC Grant RGPIN 356107-2009.
4The in vitro and in vivo DNA binding data were funded by the U.S. National Institutes of Health
(NIH) under Grant GM704403 (to MDB and MBE). Work at Lawrence Berkeley National Laboratory
was conducted under Department of Energy Contract DE-AC02-05CH11231.
5Not affiliated with Lawrence Berkeley National Laboratory now.
Key words and phrases. SELEX, transcription factor binding.
928
A MODEL FOR SELEX 929
8% of the genes encoded in the human genome. A comprehensive understanding of
the behavior of these proteins will aid in our understanding of key developmental
processes, including body patterning, brain development and tissue specification.
One in-vitroassay, known as Systematic Evolution of Ligands by EXponen-
tial enrichment (SELEX), indirectly measures the affinity of a transcription factor
binding to various DNA sequences. SELEX was introduced in the 1990s by Tuerk
and Gold (1990) and Ellington and Szostak (1990). It has been used in a number
of genomic studies [e.g., Kim et al. (2003) and Freede and Brantl (2004)] and for
the purposes of drug discovery [e.g., Guo et al. (2008) and Ng et al. (2006)]. In
genomic studies, SELEX has been used to identify the highest affinity recognition
sequences for target proteins.
More recently there has been an emphasis on using SELEX data to estimate not
just the highest affinity sequences but also a matrix for the free energy of bind-
ing. Using the free energy matrix, one can build a model which takes as input a
nucleotide sequence and outputs the affinity of the sequence for the transcription
factor. With a flexible model, one can scan the genome to find high to medium
affinity putative binding sites. Having such a model is important since the nu-
cleotide sequence with the highest affinity for the transcription factor might not be
occupied in-vivo. For instance, due to DNA folding and histone interference, the
highest affinity site may be inaccessible to the transcription factor. Also, the speci-
ficity of the site may play a role. That is, a medium affinity site surrounded by very
low affinity sequences might be a functionally more important binding site than a
high affinity site surrounded by other high affinity sites. Such requirements have
led researchers to consider thermodynamic models for SELEX. Djordjevic and
Sengupta (2006) and Zhoa, Granas and Stormo (2009) are two thermodynamic
models for SELEX that precede ours. We will clearly illustrate how our model di-
verges from Djordjevic and Sengupta (2006) and Zhoa, Granas and Stormo (2009)
in Sections 2 and 3 after we describe the SELEX experiment in detail.
Our model is a result of a large collaboration, the Berkeley Drosophila Tran-
scription Network Project (BDTNP). The goal of the BDTNP is to understand the
early developmental transcription factors in fly embryos. As part of this collabora-
tion, in-vitro SELEX, in-vivo ChIP-chip and, most recently, in-vivo ChIP-seq have
been performed on many transcription factors. Although the in-vivo ChIP-seq re-
sults are extremely important because they identify regions along the genome to
which a transcription factor actually bound at an instant in time in a particular de-
velopmental stage in a specific tissue or cell lineage, we believe that the in-vitro
SELEX experiment is still extremely relevant for two reasons.
First, the ChIP-seq assay is exceedingly expensive, currently at a minimum cost
of $5K per sample. To fully understand a developmental process, it would be nec-
essary to conduct ChIP-seq in every tissue or cell lineage in an animal throughout
its development. At $5K per sample this cost is already prohibitive before we even
account for the manpower required. The in-vitro binding data from SELEX allows
us to reason about all locations in a genome that might be bound by the transcrip-
tion factor of interest in any sample. Obviously, this can be very powerful when
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combined with information from other in-vivo assays, such as DNasel accessibility
experiments [Li et al. (2011) and Kaplan et al. (2011)].
Second, there is great value to obtaining the qualitative, thermodynamic esti-
mates of protein/DNA binding affinities that we model in this paper from SELEX
data. Ultimately, biologists would like to understand the relationship between tran-
scription factor binding patterns and gene expression [Ay and Arnosti (2011)].
Transcription factors have been shown to work together in complex spatial ar-
rangements in order to modulate gene expression [Biggin (2011)] and the dynam-
ics of these spatial configurations and their effects on transcription initiation can
not be observed by ChIP-seq or any other widely utilized assay. Such critical as-
pects of gene regulation can, at present, on a large scale, be inputted only com-
putationally, using models of protein/DNA binding affinities [Ravasi et al. (2010),
Boyle et al. (2010) and Kaplan et al. (2011)]. Therefore, models such as the one
we propose here based on SELEX data will continue to be an important area of
computational biology for the foreseeable future.
2. The SELEX assay and likelihood for the model. A typical SELEX ex-
periment begins in round one with a solution of random double stranded DNA
oligonucleotides and a transcription factor. In the application presented in this
paper the oligonucleotides are 16 base pairs long sequences and are flanked by
additional DNA sequences.
The oligonucleotides react with the transcription factor and eventually a dy-
namic equilibrium is reached where the concentrations of bound oligonucleotides,
unbound oligonucleotides and unbound target are constant. After equilibrium is
reached, the bound oligonucleotides are separated from the solution. Next, a poly-
merase chain reaction (PCR) is performed on the oligonucleotides sampled from
the end of round one. PCR chemically amplifies the quantity of DNA present in
a way that does not significantly change the frequency distribution of oligonu-
cleotides. At this point, a sample is taken for sequencing, and the remaining
oligonucleotides are entered into round two. The main steps for round one of SE-
LEX are depicted in Figure 1.
Round two of SELEX proceeds exactly as round one, except that the initial pool
of oligonucleotides is the set of bound oligonucleotides from round one that went
through PCR but were not sequenced. Thereafter, the assay proceeds as before:
FIG. 1. The main experimental steps for round one of a SELEX experiment.
A MODEL FOR SELEX 931
TABLE 1
Example of first ten sequences Si and their frequencies
li,3 collected after the third round of a SELEX
experiment for the transcription factor Bicoid
Si li,3
TCCCATTAATCCCACC 2
GGTGTCGGTTTAAGCG 2
CTGATTAATCCGAGTG 1
TGAGATTCCATACCCT 1
TGTGAGGATATGTTTC 1
TGGGGTTGGATTAAAG 1
GGATTAGGGTTAAGCA 1
GACCCCGGCCTAATCC 1
GGTAATCTCGGGATTA 1
TGGACGGATTACGCGG 1
the oligonucleotides react with the transcription factor and, after equilibrium is
reached, the bound oligonucleotides are selected and PCR is performed. A sample
is taken for sequencing and the remaining oligonucleotides are entered into round
three. These steps are repeated for as many rounds as the experimenter desires; see
Ogawa and Biggin (2011) for full experimental details.
The outcome of a SELEX experiment is observed by sequencing the oligonu-
cleotides that are sampled at the end of each round. That is, after performing the
assay, the results are a list of sequenced oligonucleotides and usually meta-data,
such as the SELEX round in which each oligonucleotide was sequenced, the con-
centration of unbound transcription factor in a particular round, and/or the temper-
ature at which the experiment was performed.
Each sequence is denoted by Si , where i enumerates over all the different se-
quence types. Letting k represent the length of the sequences and carefully ac-
counting for palindromes and reverse palindromes, for our double stranded DNA
application i = 1, . . . , n where n = 2k−1 + 4k−1. We let r identify the round num-
ber beginning with r = 0 for the initial random pool of sequences. The number of
times sequence type Si is observed in round r is represented by li,r . Table 1 shows
the first ten 16mers Si and the number of times each sequence appeared lir in
round r = 3 of a SELEX experiment for the transcription factor Bicoid. Although
we only show ten sequences, a total of 1324 unique sequences Si were observed
in round 3 of the SELEX experiment depicted in Table 1.
A complicating factor of SELEX is that the length of the binding site l to the
transcription factor is less than the length of the sequences k. In the application of
this paper we have k = 16 and we estimate the binding site length of Bicoid l to
be at most 10. All previous methods, including Djordjevic and Sengupta (2006)
and Zhoa, Granas and Stormo (2009), for analyzing SELEX data use an alignment
step prior to analyzing the SELEX data. Such aligners [e.g., Multiple Em for Motif
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TABLE 2
Ten aligned sequences from a SELEX experiment for
the transcription factor Bicoid. The sequences here
were aligned assuming a binding site of length l = 8
bj
ATA TTAATCCG ATAAC
CACCC TAAATCTT CGT
TTAATCCA GCGCATCA
ACCC TTAATCCC CCCA
CAACC TTAATCCC
TAA TCCCTCCT AATCC
T TTAATCCT GATCCCC
GGA TTAACTCG GATTA
GAGAGG TTAATCCA CT
GTAC CAAGTCAC CACA
Elicitation (MEME), Bailey et al. (2006)] are not based on the thermodynamics of
binding. For each kmer, these aligners will output their “best guess” for the lmer
to which the sequence Si is bound. We denote the lmer binding sites by bj . For
example, Table 2 shows ten aligned sequences from a SELEX experiment for the
transcription factor Bicoid. The sequences are aligned for a binding site of l = 8
using an aligner written in the Biggin lab by Stuart Davidson.
Previous models for SELEX take the estimated binding site sequences bj from
an aligner as input. Our model selects binding sites dynamically as part of the
optimization. That is, the model takes the full kmer Si sequences that were se-
quenced after each round of the SELEX experiment as input. The likelihood (2.1)
is parametrized in terms of Pr(Si), where Pr(Si) denotes the probability of select-
ing sequence Si in round r . In Section 3 we provide the parametrization for Pr(Si)
in terms of the free energy, G, a thermodynamic measure of affinity. Letting R
denote the total number of rounds for the SELEX experiment, we have
L(G|l11, . . . , lnR) =
R∏
r=1
(
n∏
i=1
Pr(Si)
lir
)
.(2.1)
It is easily seen from the likelihood (2.1) that our model for SELEX can take as
input data from all rounds of a SELEX experiment. This is important, as there is
evidence that a range of affinities is required to properly estimate the free energy,
G [see the review article Djordjevic (2007)]. Our model for SELEX is the first
model to use data from all rounds of the experiment; previous models use only
data from the last round which consists of high affinity sequences.
3. Parametrization of the model. Section 3.1 describes how the probabil-
ity of a sequence Si binding to the transcription factor in round r , tr (Si), is
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parametrized in terms of the Gibbs free energy G. Section 3.2 provides the
parametrization of the probabilities Pr(Si) of drawing Si from round r . Ap-
pendix A gives the necessary chemical background.
3.1. Probability of a sequence Si binding. In SELEX, we have multiple
oligonucleotide types Si in solution. At dynamic equilibrium in round r , the prob-
ability of any copy of type Si being bound at a particular instant is equal to the
fraction of Si , that is, bound, tr (Si). Letting [TF :Si]r and [Si]r represent the long
term average concentrations of the bound product and unbound sequences Si in
round r , we have
tr (Si) = [TF :Si]r[TF :Si]r + [Si]r .(3.1)
We are interested in modeling the affinity of oligonucleotides that bind in a se-
quence specific manner to the target. Specific binding involves hydrogen bonding,
van der Waals interactions and other short-range forces. Sequence independent
binding also occurs. This is due in part because oligonucleotides bind weakly via
electrostatic forces [see von Hipple (2007)], and because a small percentage of
DNA will nonspecifically associate with the bead or non-DNA binding surfaces of
the target. Thus, even oligonucleotides that do not bind to the target specifically
can be present in later rounds. We make three assumptions concerning specific
binding for any oligonucleotide type Si :
1. All identical copies of the same oligonucleotide type Si bind at the same
subsequence bj . We refer to this subsequence as the binding site.
2. The subsequence bj is assumed to be of fixed length l and independent of
the oligonucleotide type Si in which it is contained.
3. The binding site bj for each oligonucleotide type Si is that subsequence
which has maximum affinity according to the proposed model.
These correspond to the assumptions that the binding affinity of the sequence is
solely a function of the binding site and that there is only one binding site per
oligonucleotide.
Given these assumptions and letting [TF]r represent the long term average con-
centration of unbound transcription factor at dynamic equilibrium in round r , we
can use (A.1), (A.4) and (3.1) to write
tr (Si) = [TF]r exp((−G(Si))/(RGasT ))1 + [TF]r exp((−G(Si))/(RGasT )),(3.2)
where G(Si) ≡ G(b(Si)) and b(Si) maximizes G among all bj ’s of the
length l we have specified contained in Si .
In a SELEX experiment, tr (Si) can also be viewed as the conditional probability
that a particular molecule of the species Si is bound at the end of round r given
that it is present at the beginning of round r . Formally,
tr (Si) ≡ P [Si bound at the end of r|it is present in r].(3.3)
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Defining ̂[TF]r to be the concentration of the transcription factor at a particular
instant, we obtain t̂r (Si),
t̂r (Si) =
̂[TF]r exp((−G(Si))/(RT ))
1 +̂[TF]r exp((−G(Si))/(RT ))
,(3.4)
which is an estimate of tr (Si). We expect that the instantaneous concentrationŝ[TF]r , ̂[TF :S]r and [̂S]r will vary within 5% of their long term average concen-
trations [TF], [TF :S] and [S].
It is very difficult to measure the amount of transcription factor that is “active”
in a binding reaction, versus denatured or otherwise nonfunctional. Hence, we do
not have measurements for̂[TF]r and this causes an identifiability problem when
estimating G. The problem is easily remedied by estimating G instead. See
Appendix B.1 for further discussion.
Although the notation differs, our formulation for the probability of a sequence
type Si binding in round r , t̂r (Si), resembles the parametrization first introduced
by Djordjevic and Sengupta (2006) and later used by Zhoa, Granas and Stormo
(2009). The thermodynamic formulation (3.2) includes competitive binding be-
tween oligonucleotides Si since the Si are all competing for the unbound tran-
scription factor. As we search all possible binding sites of each oligonucleotide
type Si for the optimal site, our model takes alignment into account implicitly, un-
like Djordjevic and Sengupta (2006) and Zhoa, Granas and Stormo (2009) which
either use a pre-alignment step as in Table 2 or work on data with k = l.
3.2. Probability of drawing a sequence Si . Next we express the distribution of
bound sequences in terms of (3.4). We first assume that each sequence is present in
an initial amount C0 in round zero. We then make the assumption that each PCR
step replicates each molecule of type Si Ar times on average in round r . Then,
after the r th round of selection the amount of Si is
C0
r¯∏
r=1
Ar t̂r (Si).
Dividing the total amount of Si after round r¯ by the total amount of all sequences
after round r¯ gives an estimate of the frequency distribution of bound sequences at
the end of round r¯ . Formally,
Pr¯(Si) = P [Si is sequenced in round r¯] =
∏r¯
r=1 t̂r (Si)∑
all Sj
∏r¯
r=1 t̂r (Sj )
.(3.5)
Djordjevic and Sengupta (2006) assume that all the sequences they see in the
last round bound the protein and all the sequences they do not see did not bind.
Hence, their likelihood differs significantly from ours. Like us, Zhoa, Granas and
Stormo (2009) account for the multinomial sampling in (3.5). Zhoa, Granas and
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Stormo (2009) also account for extra variability generated during amplification by
PCR. Both Zhoa, Granas and Stormo (2009) and us fail to correct for the case in
which zero oligonucleotides of a particular species are bound in round r . The large
oligonucleotide counts makes this a reasonable approximation. For instance, in the
data we study in Section 5, each 16mer species had an average of 65,000 copies in
round zero.
As discussed in Section 3.1, it is possible for oligonucleotides to make it though
the selection step via a variety of mechanisms, including nonsequence mediated,
electrostatic protein–DNA interaction (nonspecific binding), DNA–DNA interac-
tions or DNA–apparatus interactions (experimental error). We account for such
sequences in our model, and refer to the effects that result in their selection col-
lectively as Junk Binding. If cJ is a constant between 0 and 1, then we can modify
our equations to allow for junk binding as follows:
t̂r (cJ , Si) = ((1 − cJ )t̂r (Si) + cJ ).
Our parametrization of the junk binding is different from Djordjevic and Sengupta
(2006) and Zhoa, Granas and Stormo (2009) who both use only a thermodynamic
parametrization for the nonspecific binding.
3.3. Binding model. The binding model is the relationship between the actual
DNA sequence of a binding site bj and the free energy G. So far we have for-
mulated our model in complete generality with respect to the binding model. The
most widely applied model is an additive one. The additive model was used in
both Djordjevic and Sengupta (2006) and Zhoa, Granas and Stormo (2009). Such
a model assumes that each base pair of DNA makes some contribution to the total
binding affinity independent of all other base pairs in the binding site. Represent-
ing the nucleotide base pair at position k in bj as ok , and letting εt (ok) represent
the indicator function
εt (ok) =
{1, if ok = t,
0, otherwise,
we write the elements of the energy matrix as λkt ,
G(bj ) =
l∑
k=1
∑
t∈{A,C,G,T }
λktεt (ok).(3.6)
As before, the length l represents the length of the binding site. The parameters to
be estimated are the λkt from the energy matrix.
It is important to note that our additive model (3.6) does not correspond to a
Position Weight Matrix (PWM). In a PWM the nucleotide positions are treated in-
dependently. In our notation this means that the probability of sequence Si binding
to the transcription factor, tr (Si), will equal a product of probabilities where each
probability corresponds to a position in the sequence and the value of each prob-
ability is determined by the nucleotide at the corresponding position. Our model
deviates from such an independence model in two important ways:
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• By assuming that the binding of a sequence is determined by a smaller binding
site, our model permits considerable dependence between nucleotide positions
and sequences well separated in hamming distance. If we group the sequences
by the binding sites that give minimal free energy, we see that the distribution
of binding probabilities over sequences is a mixture of probability distributions,
each of which, ignoring thermodynamic considerations, could be characterized
by PWM.
• Even when the sequence and binding site coincide, that is, when k and l are
equal, the probability of a sequence Si binding tr (Si) is modeled by a log odds
model. Rearranging equation (3.4),
log
(
tr (Si)
1 − tr (Si)
)
= log([TF]r ) − G(Si)
RT
.
4. Optimization. This section discusses the optimization of our model. In
particular, Section 4.1 explains how we simulate to simplify the denominator of
Pr(Si) and Section 4.2 discusses the numerics of the optimization procedure.
There are three identifiability issues with our model that are easily overcome. The
identifiability issues are presented in Appendix B.
4.1. Denominator of Pr(Si). For k = 16 the number of oligonucleotide types
in the initial random pool is 215 +415. It is infeasible to include all oligonucleotide
types in the denominator of (3.5). We estimate the denominator using Monte Carlo
and take a simple random sample of oligonucleotides by selecting nucleotide base
pairs from a uniform distribution. Our approach differs from Zhoa, Granas and
Stormo (2009) who discretized the energy distribution in order to simplify the
denominator before numerically optimizing to estimate the free energy matrix G.
4.2. Numerical optimization. With regards to our model, a point not yet dis-
cussed is the difficulty of maximizing the likelihood. If [TF]r is “small,” then the
denominator in (3.4) can be approximated by one. The likelihood (2.1) will sim-
plify, and the optimization between each alignment step becomes a convex opti-
mization problem. However, since we avoid making simplifications regarding the
concentration of a transcription factor in each round, the optimization is more dif-
ficult, as discussed below.
There are substantial computational and algorithmic difficulties in fitting the
model. Standard optimization techniques are often ineffective because the likeli-
hood surface is neither convex nor differentiable. In particular, the lack of continu-
ous derivatives makes gradient descent methods like Broyden–Fletcher–Goldfarb–
Shanno (BFGS) [Nocedal and Wright (2006)] unstable. In addition, the lack of
convexity means that line search methods [Nelder and Mead (1965)] tend to be-
come trapped in local maxima. In view of these considerations, we have had suc-
cess using downhill simplex methods [Powell (1964)] from a large set of random
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starting locations. This method is, empirically, stable. The software tool presented
in the supplementary material [Atherton et al. (2012)] implements this method.
The simulations and results in Section 5 were all produced using the provided
software tool.
5. Results. In Section 5.1 we demonstrate how our model works on simulated
data. Section 5.2 applies our model to Bicoid SELEX data from the Biggin Lab.
We then compare the estimates from our model to estimates made from an in-
vitro multiplex assay experiment in the Biggin Lab and to estimates made from
the Binding Energy Estimates using the Maximum Likelihood (BEEML) model of
Zhoa, Granas and Stormo (2009) in Section 5.3.
Finally, we see how our model performs versus other published methods when
searching for transcription factor binding sites along the genome. In Section 5.4 we
observe that for the transcription factor Bicoid there is good agreement between the
putative binding sites predicted by an in-vivo ChIP-chip experiment performed in
the Biggin Lab and all the other published methods we compare it with; however,
the agreement is strongest between the ChIP-chip experiment and the results of
our model applied to the SELEX data for Bicoid.
We have chosen to explain the results from Bicoid in detail because it has been
studied extensively in the literature and we have multiple replicates of the SELEX
experiment, the multiplex assay experiment and the ChIP-chip experiment. The
protocol for the SELEX experiment is provided in Ogawa and Biggin (2011).
5.1. Simulations. To explore the properties of our estimation procedure, we
simulated data under our model and refit the model parameters from the simulated
data. The energy model that we simulated under is a plausible model for binding of
the Bicoid homebox which is strongly attracted to sequences that include TAAT. In
fact, the energy matrix used for the simulation is the matrix estimated in Table 3.
To simulate data under the SELEX model, we generated one million 16mer
random sequences uniformly, which we refer to as round 0. Then, for rounds r =
1, . . . ,4, we keep each sequence in round r −1 with the probability given by (3.2).
To simulate the PCR duplication process, in which the number of oligonu-
cleotides is typically much larger than the number of PCR molecules, we repeat-
edly selected a sequence at random and duplicated the selected sequence, until we
had one million sequences.
After we had reached one million sequences, we randomly sampled 2000 of
these without replacement. The 2000 sequences are the data for round r , which we
fed into our model. The other sequences formed the selection pool for round r −1.
In Figure 2 we present boxplots of the estimated parameter values for 32 simula-
tions. We simulate our Bicoid SELEX data situation of having a binding site length
of l = 10 inside random 16mer sequences Si . As can be seen, under the model, our
procedure provides biased results. In our simulations, the binding strength of the
consensus sequence is overestimated. We believe this bias will also be present but
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FIG. 2. Boxplots of the free energy parameters estimated from the 32 simulations. The values that
generated the simulations are shown by red crosses.
hopefully smaller in magnitude when real SELEX data is analyzed, since a real
SELEX experiment will begin in round 0 with many, many more sequences that
1 million. To the best of our knowledge, the bias is present due to the fact that we
assume in our model that every sequence type Si is present in each round r of the
SELEX experiment. In reality, of course, and in our simulations, weaker sequences
will not make it to later rounds of SELEX. This will make the consensus sequence
look stronger than it really is.
Many more simulations are provided in the supplementary material [Atherton
et al. (2012)]. It appears that as the stringency of the experiment is increased (either
by decreasing the amount of the transcription factor or by increasing the energy
matrix) the bias is increased. Also seen in our simulations in the supplementary
material [Atherton et al. (2012)] is that the bias is also present and much bigger in
magnitude in the BEEML model. Of course, the BEEML model makes the same
assumption as us that every sequence type is present in each round of SELEX.
Unfortunately it is impossible to know exactly what sequence types are in each
round r of a SELEX experiment. Since we wanted to include data from all rounds
of a SELEX experiment and include alignment in our model, we are forced to
assume that all possible sequence types are present in every round. In our earliest
efforts to model SELEX data we used models which only included the last round
of SELEX and we assumed that the only binding sites bi that were present were
the binding site types that were observed. Of course these models required a pre-
alignment step and could only accept data from the last round of SELEX.
5.2. Bicoid SELEX data. Our SELEX model was run on output from all four
rounds of the Bicoid SELEX experiment. Here k = 16 and l = 10. The G ma-
trix is given in Table 3. The sequence with the highest affinity to Bicoid is called
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TABLE 3
The Gibbs free energy matrix estimated from a SELEX experiment on the transcription factor Bicoid
A C G T
1 −4.722516 −5.729347 0.000000 −6.251779
2 −7.447426 −5.981440 0.000000 −16.853690
3 0.000000 −6.946246 −15.701235 −8.529272
4 −7.746046 −15.548042 −12.535315 0.000000
5 −7.989755 −7.201358 −24.708969 0.000000
6 0.000000 −9.611195 −8.497223 −5.336888
7 −0.505663 −19.926999 0.000000 −4.445374
8 −1.836787 −0.228140 0.000000 −0.945140
9 −1.841359 −1.612913 0.000000 −1.417988
10 −1.431632 −1.539663 0.000000 −0.235633
the consensus sequence. Our consensus sequence is GGATTAGGGG (or equiva-
lently CCTAATCCCC). We have set the energy of the consensus sequence to be 0
in Table 3.
5.3. Comparison to the multiplex assay experiment and BEEML. In addition
to SELEX, the Biggin Lab has also produced an in-vitro multiplex assay experi-
ment. In this multiplex assay experiment a small number of sequence types Si are
produced. Usually the consensus sequence is known a priori (e.g., from a SELEX
experiment) and the sequence types Si produced for the experiment vary from the
consensus sequence at one or two positions only. As in the SELEX experiment,
the Si are entered in solution with the transcription factor Bicoid. The solution is
allowed to reach equilibrium and then the bound sequences are separated from the
transcription factor. Since there are very few sequence types Si present in this ex-
periment, one can obtain a much more accurate measure of the amount of bound Si
than in a SELEX experiment. Using the thermodynamic concepts presented in this
paper, one can easily use the measured amounts of each bound sequence type to
directly calculate a G matrix. The results of the multiplex assay experiment
described above for Bicoid are shown in green in Figure 3.
To compare our model to the BEEML model of Zhoa, Granas and Stormo
(2009), we had to pre-align the sequences Si for a binding site of length ten. To do
the alignment, we used MEME [Bailey et al. (2006)]. We considered using MEME
to directly align the sequences and then input these sequences into the BEEML
model; however, when aligning sequences MEME clusters like sequences together
and also eliminates sequences which do not fit according to their model. Hence, we
decided it was preferable to run MEME and construct a mean PWM based on the
output from round four of the SELEX experiment. We then used the PWM to find
the highest affinity subsequence of length ten in each 16mer Si from rounds three
and four of the SELEX experiment. These subsequences were the aligned binding
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FIG. 3. Estimated G matrices from (1) a multiplex assay experiment from the Biggin Lab
(green), (2) our model applied to all four rounds of a SELEX experiment for Bicoid (blue), and
(3) the BEEML model of Zhoa, Granas and Stormo (2009) applied to data from rounds three and
four of the same SELEX experiment for Bicoid (grey).
sites that were given to the BEEML model as input. The results of BEEML are
shown in grey in Figure 3.
Finally, as described in Section 5.2, we ran our model on all rounds of a SELEX
experiment for Bicoid. The results are plotted in Figure 3 in blue.
From Figure 3 we see that the consensus sequence for the multiplex assay exper-
iment is CTTAATCCCC and the consensus sequence for BEEML is TGTAATTGGG.
Recall from Section 5.2 that the consensus sequence for our model is CCTAATC
CCC. It is clear that all three models pick up the TAAT homebox which is clearly
the most important factor in determining the affinity of a subsequence to Bicoid.
Also seen from Figure 3 is how deleterious a mutation in the homebox is to bind-
ing. Any mutation from TAAT at positions three to six leads to a very substantial
decrease in G. All models show that mutations from the consensus sequence at
positions nine and ten are not very critical to binding. The three models also indi-
cate that positions one and two are weakly critical to binding; however, BEEML in-
dicates it is deleterious to have nucleotide base A at positions one and two, whereas
our model and the multiplex assay do not show the same deleterious effect. There
are other obvious instances where the BEEML model deviates significantly from
our model and the multiplex assay experiment.
As for why the BEEML model deviates quite a bit from our model and the
multiplex assay experiment for certain nucleotide estimates at certain locations,
a main reason is most likely the need to pre-align using MEME, that is, the output
we see for BEEML will be heavily influenced by MEME. Our model aligns during
the optimization of the likelihood and, hence, unlike MEME, our alignment is
based on thermodynamic principles. There are also important differences between
BEEML and our model. Both BEEML and our model are thermodynamic models
run on the same SELEX experiment, however:
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• BEEML accounts for the nonspecific energy of binding. Although our model
can account for the nonspecific binding, in this instance, it was run without
accounting for nonspecific binding.
• BEEML accounts for errors in the PCR step. We have chosen not to account for
that explicitly in our model.
• BEEML also has an expression similar to our expression (3.5) for Pr(Si). The
problem both models encounter is that there are too many terms to enumerate in
the denominator. As described in Section 4.1, we use Monte Carlo to overcome
this. The BEEML model takes a different approach similar to Djordjevic and
Sengupta (2006) where they discretize over a user defined number of energy
levels.
• Our model uses data from all rounds of the experiment. Furthermore, we care-
fully model the sequence enrichment from one round to the next. The code for
BEEML accepts data from two rounds of SELEX, however, there is no indica-
tion in Zhoa, Granas and Stormo (2009) that they correctly model the progres-
sion from one round to the next.
• The final likelihoods for our model and BEEML are different and optimization
schemes used are also different.
Hence, although the BEEML model has offered significant improvements to the
original Djordjevic and Sengupta (2006) model, we believe that our model offers
further important improvements.
Of course, we also see that our model estimates deviate slightly from the mul-
tiplex assay estimates and we hope that in these instances our model is providing
good estimates for the G matrix since we are using data from many, many
more sequence types Si than the multiplex assay experiment. In particular, we are
including sequences with a full range of affinities from low to high.
As the G energies from the multiplex assay are calculated directly from
the thermodynamic equations, we do not anticipate a big bias in the multiplex
assay estimates. There does not seem to be any consistent difference between our
model estimates of G and the estimates from the multiplex assay experiment.
This observation supports our hypothesis that the bias observed in our SELEX
simulations will be reduced when our model is applied to real data since in a real
SELEX experiment there are many more sequences present and, hence, many more
low affinity sequences will make it through to later rounds than in our simulation.
Basically, we think that the assumption of each sequence type being present in each
round is more valid in the real data situation than in the simulated data situation.
5.4. Comparison in an in-vivo setting. Using the G matrix estimated by
our model on the Bicoid SELEX data in Table 3, we scan the genome of Drosophila
Melanogaster and compare the results of our model and three other popular models
to the results of an in-vivo ChIP-chip experiment.
The Berkeley Drosophila Transcription Network Project (BDTNP) has gener-
ated SELEX and ChIP-chip data for Bicoid. ChIP-chip data measures the genome
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FIG. 4. Smoothed average of predicted binding sites for four models at ChIP-chip peaks. The leg-
end is as follows: Atherton et al. represents the model discussed in this paper, MEME represents
Bailey et al. (2006), Segal represents Segal et al. (2006) and Berman et al. represents Berman et al.
(2004). The fixed parameters (as described in Appendix C) for the analysis of the ChIP-chip data are
np = 100, ws = 4000, ns = 100, and st = 0.999. The peaks are aligned so that the center of each
peak, defined as the highest point in the peak, appears at 0 on the x-axis.
wide relative levels of occupancy for a single protein of interest. We used the BD-
NTP ChIP-chip data and a simple, nonparametric method to validate and compare
our Bicoid model with a PWM derived from MEME [Bailey et al. (2006)] and
two models from the literature [Segal et al. (2006) and Berman et al. (2004)]. All
four methods show strong agreement with the in-vivo ChIP-chip data, however,
our model has the strongest agreement; see Figure 4.
The ChIP-chip experiments identified thousands of genomic regions to which
Bicoid binds. This data has been shown to provide a quantitative measure of rel-
ative occupancy. That is, regions can be assigned a score, and those scores have
been shown to be reproducible between biological replicates [Li et al. (2008) and
MacArthur et al. (2009)]. From these and other observations, the authors con-
cluded that the high scoring regions correspond to those with the highest net occu-
pancy of bound factor.
Because of the complexity of intracellular processes, a binding model alone
does not provide enough information to predict the results of a ChIP-chip exper-
iment. For instance, without additional data, we have no way of modeling the
inhibitory affect of chromatin structure. However, we can still use the identified
binding regions to test the validity of our SELEX model and data.
If a binding model is identifying true in-vivo binding sites, then we expect the
number of high affinity sites predicted by our model to be higher near ChIP-chip
peaks. Roughly, we compared the binding models by measuring the enrichment
of identified binding sites as compared to the genomic background. There were
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several variables that we controlled for; we explain the method in detail in Ap-
pendix C. We plotted the results of this analysis for our model and competing
models in Figure 4.
Absent from our comparison in Figure 4 is the Zhoa, Granas and Stormo (2009)
model. Since, as discussed in Section 5.3, we have to pre-align the sequences of the
SELEX experiment using MEME, the output in Figure 4 after transformation by
the sequence ranks will be very near to the output of MEME presented in Figure 4.
6. Conclusion. The model presented here attempts to infer a comprehensive
map of the sequence specific binding affinities between double stranded DNA and
a transcription factor from a SELEX experiment. There exist a variety of assays,
including ChIP-chip, that attempt to measure the average binding behavior of a
protein in a population of cells. However, only in vitro assays like SELEX can pro-
vide precise thermodynamic models of protein/DNA interactions for downstream
models of transcriptional control.
To make accurate inference from SELEX data, researchers have left the tradi-
tional empirical approaches such as PWMs and recently turned to creating models
for SELEX based on the physical chemistry of binding. The goal of these mod-
els is to estimate the free energy of binding, G, matrix. Often the exact binding
site length l is unknown a priori, hence, SELEX experiments are performed with
a sequence length k greater than l. Also, by taking a large k, as in the Biggin Lab,
once a random pool of sequences has been generated, SELEX experiments can be
performed for many transcription factors with varying binding site lengths l. Our
model for SELEX is the first model capable of accepting data of the form k > l.
Other models for SELEX can only accept data with k = l or require an alignment
step a priori. Another important feature of our model is that it accepts data from
all rounds of the SELEX experiment. This is crucial for estimation of G, since
a mix of oligonucleotides that have a range of affinities for the transcription factor
are required. Previous models only use data from the last round of the SELEX ex-
periment and hence base their estimates on oligonucleotides with a high affinity to
the transcription factor.
The success of our model is demonstrated by applying our model and three
others to predict the DNA recognition sites enriched in an in-vivo ChIP-chip ex-
periment. The in-vivo ChIP-chip experiment indicates the in-vivo occupancy of
the transcription factor along the genome. A prior, it may not have been the case
that the affinity of a sequence for a transcription factor as measured in an in-vitro
experiment is a good predictor for binding sites occupied in-vivo, even after taking
into account of the influence of other proteins, such as nucleosomes, on occupancy
in vivo. However, we have found that for the transcription factor Bicoid the recog-
nition sites used in-vitro and in-vivo are very closely related. Hence, we can use
the in-vivo ChIP-chip experiment as validation when comparing different models
and motifs for binding. It is important that a comparison of models be made with
the ChIP-chip experiment, as this can serve as a gold standard for binding affinity;
otherwise, finding that two models produce different motifs or different energy ma-
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trices is insufficient to determine which model is performing better. Our success us-
ing results from an in-vivo experiment to validate the results of an in-vitro experi-
ment suggests that SELEX does provide a quite accurate, fine scale model of the in-
trinsic DNA recognition properties of a transcription factor. The results of our com-
parison in Section 5.4 demonstrate that our model outperforms the other models.
Preliminary results suggest that varying the additive G parametrization of our
model would provide the biggest predictive improvement. For instance, base pair
dependencies can be added. Alternatively, one could take a feature based approach;
see Sharon, Lubliner and Segal (2008). In the case of Bicoid, a feature based ap-
proach could specifically model the TAAT homebox.
APPENDIX A: CHEMICAL CONCEPTS
The concepts introduced here can be found in the physical chemistry textbook
by Atkins (1998). We begin by considering many copies of a single oligonucleotide
species S in solution with a transcription factor TF. Furthermore, we assume that S
and TF always bind in the same configuration.
When S and TF are entered into solution with one another they will react to
form the product TF :S. We call this the forward reaction. The product TF :S will
also disassociate into S and TF; we call this the backward reaction. The following
chemical equation,
TF + S TF :S,
represents these reactions. The solution is said to be in dynamic equilibrium when
the forward rate of reaction equals the backward rate of reaction. A dimension-
less physical constant quantifying the dynamic equilibrium is the equilibrium con-
stant K . Our interest in K is that it relates directly to the change in Gibbs free
energy, G, for the reaction. The change in Gibbs free energy, G, quantifies the
affinity of S for TF. Hence, in Section 3 we parameterize our SELEX model in
terms of G.
Letting RGas represent the ideal gas constant and T the temperature in Kelvins,
we have
K = exp
(
− G
RGasT
)
.(A.1)
As we shall see below, K is unidentifiable without meta data. The meta data
was defined in Section 2.
The forward rate of reaction is proportional to the product of concentrations
of the reactants. The forward rate constant, kf , is the proportionality constant.
Hence,
Forward rate = kf [S][TF](A.2)
and, similarly,
Backward rate = kb[TF :S].(A.3)
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At equilibrium, equating (A.2) and (A.3) gives the following expression for the
equilibrium constant K :
K = kf
kb
= [TF :S][TF][S] .(A.4)
We can think of K as an expected value where the “concentrations” are averages
over time and space. In principle, we can use the observable concentrations [̂S],̂[TF] and ̂[TF :S] to estimate the theoretical physical quantity K and in turn G
[via (A.1)].
APPENDIX B: IDENTIFIABILITY
There are three types of lack of identifiability in the SELEX model outlined
below.
B.1. Identifiability between [TF]r and G. The structure of t̂r (Si) in (3.4)
reveals that the G(bj )s are not directly identifiable without knowledge of̂[TF]r .
This is because t̂r (Si) is unchanged by rescaling all the G(bj )s and̂[TF]r by the
same constant. However, with the given data, we can always estimate
G(bj ) = G(bj ) − G(bo),
where bo is a reference binding site such as a consensus sequence. Of course, if
we have meta data such aŝ[TF]r , we can estimate G(bj ).
B.2. Identifiability in additive G. Physically, we are able to identify the
total binding affinity of a binding configuration but not the contributions of the
individual base pairs. To solve this, we choose to fix the energy of the highest
affinity base pair in each position except one to be zero. Then, the value of the first
position’s highest energy base pair is interpretable as the binding affinity of the
“consensus sequence,” or the modeled highest affinity binding site. Some care is
needed in ensuring that this constraint does not interfere with whatever optimiza-
tion algorithm is chosen—such concerns are discussed in the code’s comments.
B.3. Identifiability of the binding site names. The third identifiability prob-
lem is present in any binding model which represents binding sites by their se-
quences. For any segment bj of a double stranded DNA sequence there are four
possible names. To ensure that the paramterization is physically meaningful, each
binding site must be represented by the same sequence. For example, Bicoid has a
high affinity for sequences that contain the subsequence TAATCC. As can be seen
in Table 2, it is possible to align the full sequences by the subsequences that are
closest to TAATCC in the Hamming sense. If, for instance, one were to name half
of the subsequences by TAATCC and half by ATTAGG, then the likelihood would
not optimize properly. This being said, it is irrelevant which name is chosen, as
long as it is consistent. For instance, the subsequence TAATCC could also be called
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TABLE 4
Possible binding sites of length l = 10 for the factor
Bicoid in an oligonucleotide of length 16
3′ GTTTATAATCCGCGTC 5′
CAAATATTAGGCGCAG
1 GTTTATAATC
2 TTTATAATCC
3 TTATAATCCG
4 TTATAATCCG
5 TATAATCCGC
6 TATAATCCGC
7 TATAATCCGC
CCTAAT, ATTAGG or GGATTA. For the binding model presented in Section 3.3,
the likelihood will be symmetric with four identical modes, each corresponding to
a different naming scheme for the strongest binding site. Which of the names our
code chooses is chosen, arbitrarily, to be the one with the consensus sequence, that
is, first alphabetically.
APPENDIX C: DESCRIPTION OF CHIP-CHIP COMPARISON
We compare the predictions for putative binding sites for Bicoid from our SE-
LEX model and experiment to predictions from Bailey et al. (2006), Segal et al.
(2006) and Berman et al. (2004). For validation, all four models, ours, Bailey et al.
(2006), Segal et al. (2006) and Berman et al. (2004), are used to predict the pu-
tative binding sites at genomic locations previously highlighted in a ChIP-chip
experiment. In MacArthur et al. (2009) they defined a “peak” of the ChIP-chip
experiment to be a single point in the genome where the local signal achieves its
maximum. In our nonparametric comparison of the models for the binding affinity
of Bicoid we chose to consider the np highest peaks in the ChIP-chip experiment.
To summarize our results, for each of the four models we combine the putative
binding site predictions over the np peaks in the method described below. Note that
since some models attempt to assign physically meaningful affinity scores to each
subsequence (e.g., the use of the free energy matrix in our model) and other models
assign affinity scores based on estimated probabilities or background frequencies
(e.g., the use of the PWM in MEME), an important step of our comparison is to
obtain a common scoring scale for the four models. In Section C.1 we explain how
we obtain the common scoring scale. For each of the four models, the steps in
Section C.1 are repeated at each of the ChIP-chip peaks. Section C.2 explains how
we combine and summarize the results of the np peaks for each model.
C.1. Common scoring scale. To obtain a common scoring scale for the four
models, for each model it is necessary to relate the affinity scores at the peaks to
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the affinity scores in the noncoding genome. Therefore, for each model we begin
by sampling ns intervals of size 2ws from the noncoding mappable genome that
do not overlap regions identified by the ChIP-chip experiment. Within each of
the ns intervals, we evaluate the affinity score of each subsequence of length l,
thus generating ns samples of affinity scores. Each sample provides an empirical
null distribution of affinity scores. We choose an α (e.g., α = 0.01), and in each of
the ns samples we find the αth-percentile affinity score. To calculate a threshold
affinity score, we take the median of the ns αth-percentiles. Our threshold affinity
score is denoted by ŝα .
Next, for each model, we examined a symmetric interval of fixed size 2ws
around each ChIP-chip peak. Within each of these intervals, using the chosen
model, we evaluated the affinity score of each subsequence of length l. For each
subsequence of length l in the 2ws interval around each of the np peaks, we con-
sider a position to be a “hit” if its score is greater than ŝα .
In this way, by determining if each sequence of length l near each ChIP-chip
peak is a hit or not, we can compare the four models.
C.2. Combining the results for the np peaks. For each model and each
peak, by defining each hit as a 1 and each “miss” as a 0, we obtain a binary vector
that records each position at which a hit begins. For each model, we align the np
vectors at the peaks in the 5′–3′ direction and sum across them. The resulting vec-
tor of counts records, with respect to the position of peaks, how many of the np
intervals had a hit at each relative position. We smooth these counts with a 200bp
moving average,5 and then divide the result by the expected number of hits under
a uniform null, np(1 − ŝα)−1. It is these smoothed results that are plotted for each
of the four models in Figure 4.
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SUPPLEMENTARY MATERIAL
Code for SELEX model (DOI: 10.1214/12-AOAS537SUPP; .pdf). The code
for the SELEX model used in the application of this paper is available at the above
url. Extra simulations, mentioned in Section 5.1, are also provided as supplemen-
tary material.
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